Jason Santiago, MD
Neurology with Special Qualifications in Child Neurology · Fort Wayne, INNPI 1053845289
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,191 of the $59,808 with a category attached, or 72.2%. 23 manufacturers reported payments, led by Neurelis, Inc. at 56.2% of the total. 2025 is the largest year on record at $29,618, more than ten times the $797 reported in 2022. Among neurology with special qualifications in child neurology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 213 payments — averaging $280.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$34K
- Pfizer$11K
- Livanova USA, Inc.$8K
- UCB Biosciences Inc.$5K
- AbbVie$419
- UCB, Inc.$261
- plus $1K from 17 others
Across 1 payment — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$5K
What the payments were for
- Consulting fees$1,5253%
- Speaking & faculty fees$43,19172%
- Travel & lodging$10,19817%
- Food & beverage$4,8958%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 64 | $33,633 |
| Pfizer | 13 | $11,455 |
| Livanova USA, Inc. | 31 | $8,442 |
| UCB Biosciences Inc. | 2 | $4,500 |
| AbbVie | 44 | $419 |
| UCB, Inc. | 15 | $261 |
| Argenx US, Inc. | 4 | $180 |
| Teva Pharmaceuticals USA, Inc. | 2 | $139 |
| Jazz Pharmaceuticals Inc. | 6 | $117 |
| AstraZeneca | 2 | $99 |
| Biogen | 5 | $95 |
| Neurocrine Biosciences, Inc. | 4 | $87 |
| Amneal Pharmaceuticals LLC | 5 | $76 |
| Eisai Inc. | 3 | $64 |
| Acadia Pharmaceuticals Inc | 3 | $48 |
| Banner Life Sciences, LLC | 2 | $34 |
| Amgen | 2 | $33 |
| Catalyst Pharmaceuticals, Inc. | 1 | $23 |
| SK Life Science, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$32,926
- NURTEC ODT$11,083
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$5,468
- Fintepla$4,500
- VNS Therapy$2,676
- Austedo XR$121
- VYVGART HYTRULO$120
- ZAVZPRET$109
How this compares
$59,808 in reported general payments places this provider in the 90th percentile of 25 neurology with special qualifications in child neurology providers in Indiana.
See all neurology with special qualifications in child neurology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Entacapone | 11 | $798 |
| Lamotrigine | 14 | $565 |
| RivastigmineRivastigmine Tartrate | 11 | $431 |
| Levocarnitine | 13 | $368 |
| Carbamazepine | 13 | $33 |
| Topiramate | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Fort Wayne
- Atiya KhanFort Wayne$1.2M
- Keith RidelIndianapolis$110K
- Larry SalbergMerrillville$27K
- Kofi QuistIndianapolis$18K
- Daksha VyasMerrillville$8K
- Samira El ZindSouth Bend$7K
- Kristyn TekulveKokomo$4K
- Bittu Majmudar-ShethIndianapolis$1K
- Lauren JamesIndianapolis$832
- James PappasIndianapolis$780
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.